1. Service Overview
We deliver professional GMP-compliant high-containment facility design solutions for high-risk biopharmaceutical manufacturing and R&D scenarios, covering dedicated plant design for cytotoxic drugs, high-potency APIs, oncolytic viruses, and hazardous biologic product production lines. Strictly aligned with FDA, EU GMP, cGMP and global biosafety containment guidelines, our services focus on stringent cross-contamination prevention, personnel safety protection, environmental risk isolation and full-process containment control. We resolve core industry pain points such as insufficient isolation design, incomplete pressure control and hidden biosafety hazards in traditional factory construction, providing audit-ready, high-safety and fully compliant facility design solutions for global high-end biotech enterprises and specialized pharmaceutical manufacturers.
2. Core Service Scope & Technical Specifications
Our full-range high-containment design portfolio covers systematic engineering planning and customized technical deployment for high-risk biopharmaceutical facilities. The core scope includes biosafety level zoning, independent negative pressure isolation layout, dedicated personnel and material passage separation, and full-enclosed production space design. We deliver targeted engineering schemes for high-efficiency filtered HVAC exhaust systems, closed material transfer devices, waste disinfection and treatment systems, and independent differential pressure monitoring modules. All design implementations adopt strict unidirectional airflow organization, full-space isolation structure and zero-leakage pipeline configuration, fully meeting international standards for high-potency drug containment, biosafety protection and environmental discharge compliance.
3. Technical & Quality Advantages
Differentiated from conventional general pharmaceutical plant design, our high-containment solutions adopt safety-risk-driven design logic, tailored for the high-hazard, high-isolation and high-control characteristics of special biopharmaceutical production. We embed multi-dimensional protection mechanisms including space isolation, pressure gradient locking, airflow direction control and closed material circulation into the preliminary design stage, fundamentally eliminating cross-contamination, personnel exposure and environmental leakage risks. The entire design process implements standardized safety verification, parameter calibration and full-document traceability, with complete biosafety assessment reports and compliance design documents. All design outcomes conform to global biocontainment best practices, ensuring full compatibility with international safety audits and GMP validation.
4. Industrial Value & Delivery Commitment
Our professional high-containment facility design enables pharmaceutical enterprises to safely launch high-risk and high-value biopharmaceutical product pipelines, breaking through technical barriers of high-standard biosafety manufacturing. Systematic containment design effectively reduces safety accidents, product contamination risks and regulatory non-compliance losses, realizing long-term stable and safe plant operation. We provide one-stop full-cycle technical support including safety scheme customization, biosafety standard consultation, design document delivery and on-site engineering guidance. With in-depth mastery of global biocontainment regulations and rich high-risk pharmaceutical project experience, we help clients build high-safety, audit-ready and internationally compliant specialized biomanufacturing facilities, accelerating high-value product industrialization and enhancing global market competitive advantages.
